Patient-Reported Outcomes of Long-Term Upadacitinib Use in Patients with Rheumatoid Arthritis: Interim Analysis Results of a Phase 2, Open-Label Extension Study

被引：0
|
作者：
Strand, Vibeke [1 ]
Tundia, Namita [2 ]
Friedman, Alan [2 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
501
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension
    Roeth, Alexander
    Broome, Catherine M.
    Barcellini, Wilma
    Jilma, Bernd
    Hill, Quentin A.
    Cella, David
    Tvedt, Tor Henrik Anderson
    Yamaguchi, Masaki
    Murakhovskaya, Irina
    Lee, Michelle
    Shafer, Frank
    Wardecki, Marek
    Jayawardene, Deepthi
    Yoo, Ronnie
    Msihid, Jerome
    Weitz, Ilene C.
    ECLINICALMEDICINE, 2024, 74
  • [12] Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients
    Gossec, Laure
    Danre, Agnes
    Combe, Bernard
    Le Loet, Xavier
    Tebib, Jaques
    Sibilia, Jean
    Mariette, Xavier
    Dougados, Maxime
    JOINT BONE SPINE, 2015, 82 (06) : 451 - 454
  • [13] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [14] LONG-TERM QUALITY-OF-LIFE AND PATIENT-REPORTED IMPROVEMENTS WITH GARADACIMAB FOR HEREDITARY ANGIOEDEMA: PHASE 3 OPEN-LABEL EXTENSION STUDY
    Braverman, J.
    Chapdelaine, H.
    Sitz, K.
    Katelaris, C.
    Guilarte, M.
    Longhurst, H.
    Lawo, J.
    Lumry, W.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S39 - S39
  • [15] Long-term goflkicept therapy for patients with idiopathic recurrent pericarditis: results of the interim analysis of an ongoing open-label extension study
    Myachikova, Valentina Yu.
    Maslyanskiy, Alexey L.
    Moiseeva, Olga M.
    Schedrova, Margarita L.
    Egorova, Alina N.
    Ponomar, Ekaterina G.
    Samsonov, Mikhail Yu.
    TERAPEVTICHESKII ARKHIV, 2024, 96 (09) : 892 - 900
  • [16] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [17] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [18] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Fitzgerald, Oliver
    Fleishaker, Dona
    Wang, Cunshan
    Wu, Joseph
    Hsu, Ming-Ann
    Menon, Sujatha
    Fallon, Lara
    Romero, Ana Belen
    Kanik, Keith S.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 553 - 580
  • [19] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Peter Nash
    Laura C. Coates
    Alan J. Kivitz
    Philip J. Mease
    Dafna D. Gladman
    José A. Covarrubias-Cobos
    Oliver FitzGerald
    Dona Fleishaker
    Cunshan Wang
    Joseph Wu
    Ming-Ann Hsu
    Sujatha Menon
    Lara Fallon
    Ana Belén Romero
    Keith S. Kanik
    Rheumatology and Therapy, 2020, 7 : 553 - 580
  • [20] ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study
    Cohen, Stanley
    Pablos, Jose L.
    Zhang, Nan
    Rizzo, Warren
    Muller, Gerhard
    Padmanaban, Devi
    Kivitz, Alan
    Matsumoto, Alan K.
    Kaur, Primal
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345